{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T19:27:28Z","timestamp":1740166048167,"version":"3.37.3"},"reference-count":31,"publisher":"FapUNIFESP (SciELO)","issue":"1","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends Psychiatry Psychother."],"DOI":"10.1590\/2237-6089-2019-0015","type":"journal-article","created":{"date-parts":[[2020,4,17]],"date-time":"2020-04-17T19:37:15Z","timestamp":1587152235000},"page":"48-54","source":"Crossref","is-referenced-by-count":1,"title":["Analysis of psychiatrists\u2019 prescription of opioid, benzodiazepine, and buprenorphine in Medicare Part D in the United States"],"prefix":"10.1590","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3142-2612","authenticated-orcid":false,"given":"Kevin","family":"Pan","sequence":"first","affiliation":[{"name":"Samford University,  USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shawgi","family":"Silver","sequence":"additional","affiliation":[{"name":"University of Washington,  USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Davis","sequence":"additional","affiliation":[{"name":"Christ Health,  USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2020,3]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/fampra\/cmw078","article-title":"Opioid analgesics and chronic non-cancer pain: a prescription for research in primary care","volume":"33","author":"Scherrer JF","year":"2016","journal-title":"Fam Pract"},{"key":"ref2","article-title":"Canada\u2019s prescription opioid epidemic grows despite tamperproof pills","volume":"351","author":"Dyer O","year":"2015","journal-title":"BMJ"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e225","DOI":"10.3399\/bjgp18X695057","article-title":"Patterns of regional variation of opioid prescribing in primary care in England: a retrospective observational study","volume":"68","author":"Mordecai L","year":"2018","journal-title":"Br J Gen Pract"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1176\/appi.prcp.20180009","article-title":"World opioid and substance use epidemic: a Latin American perspective","volume":"1","author":"Pacurucu-Castillo SF","year":"2019","journal-title":"Psychiatr Res Clin Pract"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"666","DOI":"10.2105\/AJPH.2018.304341","article-title":"Rising trends of prescription opioid sales in contemporary Brazil, 2009-2015","volume":"108","author":"Krawczyk N","year":"2018","journal-title":"Am J Public Health"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.15585\/mmwr.mm655051e1","article-title":"Increases in drug and opioid-involved overdose deaths - United States, 2010-2015","volume":"65","author":"Rudd RA","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"349","DOI":"10.15585\/mmwr.mm6712a1","article-title":"Overdose deaths involving opioids, cocaine, and psychostimulants - United States, 2015-2016","volume":"67","author":"Seth P","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1590\/2237-6089-2015-0041","article-title":"Assessment of dependence and anxiety among benzodiazepine users in a provincial municipality in Rio Grande do Sul, Brazil","volume":"38","author":"Schallemberger JB","year":"2016","journal-title":"Trends Psychiatry Psychother"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2105\/AJPH.2016.303061","article-title":"Increasing benzodiazepine prescriptions and overdose mortality in the United States, 1996-2013","volume":"106","author":"Bachhuber MA","year":"2016","journal-title":"Am J Public Health"},{"key":"ref10","article-title":"Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis","volume":"356","author":"Sun EC","year":"2017","journal-title":"BMJ"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1590\/2237-6089-2017-0028","article-title":"Spatial analysis and temporal trends of suicide mortality in Sergipe, Brazil, 2000-2015","volume":"40","author":"Santos ADD","year":"2018","journal-title":"Trends Psychiatry Psychother"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.drugalcdep.2015.01.027","article-title":"Trends in abuse and misuse of prescription opioids among older adults","volume":"149","author":"West NA","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jagp.2016.06.003","article-title":"A systematic review of opioid and benzodiazepine misuse in older adults","volume":"24","author":"Maree RD","year":"2016","journal-title":"Am J Geriatr Psychiatry"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/gps.4999","article-title":"Prescription opioid and benzodiazepine misuse is associated with suicidal ideation in older adults","volume":"34","author":"Schepis TS","year":"2019","journal-title":"Int J Geriatr Psychiatry"},{"series-title":"Drug coverage (Part D)","key":"ref15"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1001\/jamainternmed.2015.6662","article-title":"Distribution of opioids by different types of Medicare prescribers","volume":"176","author":"Chen JH","year":"2016","journal-title":"JAMA Intern Med"},{"key":"ref17","first-page":"1","article-title":"Opioids in Medicare Part D: concerns about extreme use and questionable prescribing","year":"2017","journal-title":"HHS OIG Data Brief"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"E106","DOI":"10.1111\/papr.12148","article-title":"The prevalence of diagnosed opioid abuse in commercial and Medicare managed care populations","volume":"14","author":"Dufour R","year":"2014","journal-title":"Pain Pract"},{"key":"ref19","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick RP","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1370\/afm.1735","article-title":"Geographic and specialty distribution of US physicians trained to treat opioid use disorder","volume":"13","author":"Rosenblatt RA","year":"2015","journal-title":"Ann Fam Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1001\/jamapsychiatry.2016.1390","article-title":"Use of opioid agonist therapy for Medicare patients in 2013","volume":"73","author":"Lembke A","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1056\/NEJMoa1505409","article-title":"Extended-release naltrexone to prevent opioid relapse in criminal justice offenders","volume":"374","author":"Lee JD","year":"2016","journal-title":"N Engl J Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(17)32812-X","article-title":"Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): A multicentre, open-label, randomized controlled trial","volume":"391","author":"Lee JD","year":"2018","journal-title":"Lancet"},{"series-title":"Medicare provider utilization and payment data: Part D prescriber","key":"ref24"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/fampra\/cmy090","article-title":"An examination of opioid prescription for Medicare Part D patients among family practice prescribers","volume":"36","author":"Pan K","year":"2019","journal-title":"Fam Pract"},{"key":"ref26","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.0040","article-title":"Assessment of changes in the geographical distribution of opioid-related mortality across the United States by opioid type, 1999-2016","volume":"2","author":"Kiang MV","year":"2019","journal-title":"JAMA Netw Open"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1590\/2237-6089-2017-0129","article-title":"The effects of physical activity on anxiety, depression, and quality of life in elderly people living in the community","volume":"41","author":"Oliveira LDSSCB","year":"2019","journal-title":"Trends Psychiatry Psychother"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1590\/2237-6089-2015-0041","article-title":"Assessment of dependence and anxiety among benzodiazepine users in a provincial municipality in Rio Grande do Sul, Brazil","volume":"38","author":"Schallemberger JB","year":"2016","journal-title":"Trends Psychiatry Psychother"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1590\/2237-6089-2015-0013","article-title":"Variables associated with health-related quality of life in a Brazilian sample of patients from a tertiary outpatient clinic for depression and anxiety disorders","volume":"37","author":"Schwab B","year":"2015","journal-title":"Trends Psychiatry Psychother"},{"series-title":"HHS awards over $1 billion to combat the opioid crisis","key":"ref30"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jagp.2018.12.026","article-title":"Medication-assisted treatment for opioid use disorder in older adults: an emerging role for the geriatric psychiatrist","volume":"27","author":"Joshi P","year":"2019","journal-title":"Am J Geriatr Psychiatry"}],"container-title":["Trends in Psychiatry and Psychotherapy"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/trends\/v42n1\/2238-0019-trends-42-01-0048.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T20:17:15Z","timestamp":1591301835000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S2237-60892020000100048&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,3]]}},"alternative-id":["S2237-60892020000100048"],"URL":"https:\/\/doi.org\/10.1590\/2237-6089-2019-0015","relation":{},"ISSN":["2238-0019","2237-6089"],"issn-type":[{"type":"electronic","value":"2238-0019"},{"type":"print","value":"2237-6089"}],"subject":[],"published":{"date-parts":[[2020,3]]}}}